李秋泽;杨成光;
LI Qiuze;YANG Chengguang;155 Central Hospital of People's Liberation Army;Henan Provincial People's Hospital;

• 1:解放军155中心医院
• 2:河南省人民医院

摘要(Abstract)：

目的:分析高迁移率族蛋白B1(HMGB1)及基质金属蛋白酶-9(MMP-9)在非小细胞肺癌及癌旁组织的表达。方法:选取70例术后经病理组织切片确诊的肺癌患者的组织标本,根据病理学检查结果,将标本分为非小细胞肺癌组和癌旁组织组,鳞癌组和腺癌组,各病理分期组,采用组织化学方法观察各分组中HMGBI与MMP-9表达。结果:免疫组化结果显示,HMGB1及MMP-9在肺癌组织中具有较高的阳性表达率,HMGB1在非小细胞肺癌组织中的阳性表达率高于癌旁对照组,两组比较差异有统计学意义(χ2=11.15,P<0.05);从病理分型看,HMGB1在肺鳞癌组中阳性表达率明显高于腺癌组,差异有统计学意义(χ2=7.232,P<0.05);非小细胞肺癌组织中MMP-9的阳性表达率高于癌旁组织组,两组比较差异有统计学意义(χ2=21.39,P<0.05);从肺癌分期来看,Ⅰ~Ⅱ期中HMGB1阳性表达有27例,阳性率为64.2%;在Ⅲ~Ⅳ期中表达阳性的有23例,阳性率为82.1%;其中在Ⅰ~Ⅱ期中MMP-9阳性表达有25例,阳性率为59.4%;在Ⅲ~Ⅳ期中表达阳性的有21例,阳性率为75%。结论:HMGB1与MMP-9在肺癌组织中具有较高的阳性表达率,考虑HMGB1与MMP-9可能共同参与了肺癌的进展过程。
Objective: To investigate the expression of HMGB1 and MMP-9 in non-small cell lung cancer tissues and Precancerous lesions. Methods: 70 stored samples of thoracic resection surgery and histopathological slide diagnosed patients with lung cancer. The specimens were divided into two groups after pathology test,non-small cell lung cancer group( NSCLC group),precancerous lesions group,squamous cell carcinoma group,adenocarcinoma group and various pathological staging groups;adopting immunohistochemical method to observe the expression of HMGB1 and MMP-9 in all groups.Results: Analysis of experimental data indicated,HMGB1 and MMP-9 in lung cancer tissue has a relatively high positive expression rate. The positive expression rate of HMGB1 in non-small cell lung cancer was higher than precancerous lesions group,difference was statistical significant( χ~2= 11. 15,P < 0. 05); pathological analysis showed that the positive expression rate of HMGB1 in squamous cell carcinoma was higher than adenocarcinoma group,which was statistically significant( χ~2= 7. 232,P <0. 05). The positive expression rate of MMP-9 in non-small cell lung cancer was higher than precancerous lesions group,and the difference was statistically significant( χ~2= 21. 39,P < 0. 05). From lung cancer staging,positive expression rate in stage I to II was found in 27 cases,positive rate was64. 2%; 23 positive cases were found in stage III to IV,positive rate was 82. 1%; MMP-9 positive expression found 25 cases in stage I to II,positive rate was 59. 4%; 21 positive cases were found in stage III to IV,positive rate was 75%. Conclusion: HMGBI and MMP-9 have a high positive expression rate in lung cancer tissues,which proves that HMGB1 and MMP-9 are closely related to the development and progression of lung cancer.

关键词(KeyWords)： 肺肿瘤;高迁移率族蛋白B1;基质金属蛋白酶-9;病理检查;组织类型
lung neoplasm;high mobility group box-B1;matrix metalloproteinases-9;pathological detection;tissue type

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 李秋泽;杨成光;
LI Qiuze;YANG Chengguang;155 Central Hospital of People's Liberation Army;Henan Provincial People's Hospital;

Email:

DOI: 10.19367/j.cnki.1000-2707.2018.04.025

参考文献(References)：

• [1]郭云娣,白光辉.胃癌组织HMGB1和RAGE蛋白表达与临床病理因素相关性分析[J].中华肿瘤防治杂志,2014,35(9):92-93.
• [2]赵国军,黄俊星,于鸿,等.HMGB1和MMP-9在食管鳞癌组织中的表达及临床意义[J].江苏医药,2015,15(9):1017-1019.
• [3]CHEN H,GUAN B,SHEN J.Targeting ONOO-/HMGB1/MMP-9 signaling cascades:Potential for drug development from Chinese medicine to attenuate ischemic brain injury and hemorrhagic transformation induced by thrombolytic treatment[J].Integrative Medicine International,2016,21(3):32-52.
• [4]张卫琴.免疫组化技术在病理诊断中的应用[J].安徽医药,2012,16(11):1700-1702.
• [5]郑伟,汪宝军,叶立民.灰度值、光学密度值与免疫组化片阳性表达强弱的关系[J].临床与实验病理学杂志,2003,19(5):566-567.
• [6]吕宏升,朱庆生,王军,等.全自动显微镜及图像分析系统处理免疫组化图像[J].中国体视学与图像分析,2004,78(1):37-40.
• [7]于萍,步宏,王华,等.免疫组化结果的图像分析与人工计数方法的对比研究[J].生物医学工程学杂志,2003,47(2):288-290.
• [8]段玉真,周晓慧,张玉娟.HMGB1、MMP9在子宫内膜癌中的表达和临床意义[J].承德医学院学报,2016,58(2):97-99.
• [9]SAPOINKOVA N,KARTVELISHVILI T,ASATIANI N,et al.Correlation between MMP-9 and extracellular cytokine HMGB1 in prediction of human ischemic stroke outcome[J].Biochimica et Biophysica Acta(BBA)-Molecular Basis of Disease,2014,48(9):1379-1384.
• [10]CHENE H,GUAN B,SHEN J.Targeting ONOO-/HMGB1/MMP-9 signaling cascades:potential for drug development from Chinese medicine to attenuate ischemic brain injury and hemorrhagic transformation induced by thrombolytic treatment[J].Integrative Medicine International,2016,39(3):32-52.
• [11]芦柏震,毛伟敏,侯桂兰,等.中晚期肺癌治疗的研究进展[J].中华中医药学刊,2012(9):1980-1982.
• [12]WANG L,LI Z,ZHANG X,et al.Protective effect of shikonin in experimental ischemic stroke:Attenuated TLR4,p-p38MAPK,NF-κB,TNF-αand MMP-9 Expression,Up-Regulated claudin-5 expression,ameliorated BBB permeability[J].Neurochemical Research,2014,28(1):97-106.
• [13]LEE C C,WANG C N,Lee Y L,et al.High mobility group box 1 induced human lung myofibroblasts differentiation and enhanced migration by activation of MMP-9.[J].Plos One,2015,39(2):116-117.
• [14]刘嘉,阮宏莹,林鹏,等.喉癌患者血清HMGB1和MMP-9表达及其临床意义[J].山东医药,2014,38(10):63-65.
• [15]赵国军,黄俊星,于鸿,等.HMGB1和MMP-9在食管鳞癌组织中的表达及临床意义[J].江苏医药,2015,46(9):1017-1019.

文章评论(Comment)：